AzTrials
AzTrials

Lumbar Disc HerniationNCT06628583

Multivariate Analysis and Risk Factors Were Used to Predict the Short-term Postoperative Pain of Degenerative Lumbar Spine

An observational study of Lumbar Disc Herniation and Lumbar Degenerative Disease, run by Hao Liu at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective of this retrospective clinical study wasto study the risk factors for short-term low back and leg pain after PLIF in patients with lumbar Degenerative disease, and to establish a risk prediction model for short-term low back and leg pain after PLIF based on relevant risk factors. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
What is being tested?
Magnetic Resonance Imaging with Contrast
How many people
936 participants
Where
1 siteChina
Study dates
20 Sep 2024to 28 Sep 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: The data of 936 patients who underwent PLIF for lumbar Degenerative disease from June 2018 to March 2023 were collected retrospectively. The patients were divided into rehabilitation group(N=501) and residual pain group(N=435)according to their postoperative pain

Who may be able to join

  • confirmed diagnosis of lumbar degenerative disease (spinal stenosis, disc herniation with lumbar instability, and lumbar spondylolisthesis), with no significant symptomatic relief after conservative treatment for more than 3 months, and in need of surgical intervention;
  • lumbar spinal fusion surgical treatment with PLIF;
  • grouping based on the presence or absence of a lumbar or limb pain with VAS ≥3 at the 3th month postoperative follow-up;
  • observational indicators including individual factors, surgical factors, spine-pelvis sagittal balance parameters, and paravertebral muscle parameters.

Who cannot join

  • those with a history of lumbar spine trauma, inflammation, tumor, or surgery; (2) those with congenital or acquired severe lumbar vertebral deformity; (3) those with severe neurological dysfunction; (4) those with incomplete baseline and follow-up data.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Medical record system and imaging system of the First Affiliated Hospital of Suzhou University, China

    Suzhou, Jiangsu, 215006

Other trials in China

About this study

The objective of this retrospective clinical study wasto study the risk factors for short-term low back and leg pain after PLIF in patients with lumbar Degenerative disease, and to establish a risk prediction model for short-term low back and leg pain after PLIF based on relevant risk factors.

Being tested
Magnetic Resonance Imaging with Contrast
Keywords
Lumbar Degenerative disease, PLIF, Sarcopenia, Sagittal bit balance, Machine learning
Medical subject headings
Intervertebral Disc Displacement, Sarcopenia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Magnetic Resonance Imaging with ContrastOther

    The study was retrospective and did not set interventions

Study groups in NCT06628583
Study groupRoleWhat they receive
Rehabilitation Groupmild/non pain group with VAS<3 at 3th months after PLIF.N=501
Receives: Other: Magnetic Resonance Imaging with Contrast
Recurrent pain groupRecurrent pain group: recurrent pain group with VAS≥3 at 3th months after PLIF.N=435
Receives: Other: Magnetic Resonance Imaging with Contrast

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. General situation of the patient

    General information such as age, sex, BMI and psychological status was collected

    Measured: Before the operation

Secondary outcomes (1)
  1. Surgical situation

    It includes the course of disease, the operation time, the amount of bone cement injected during the operation, the leakage of bone cement and so on

    Measured: 1-3 months after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Oct 2024
  2. Study start20 Sep 2024
  3. Primary completion25 Sep 2024
  4. Study completion28 Sep 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Retrospective
Enrolment
936 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06628583
Sponsor's protocol ID
(2024) Lun Yan Grant No. 518
Status last verified
Oct 2024
First submitted
3 Oct 2024
Last updated
8 Oct 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Lumbar Disc Herniation and Lumbar Degenerative Disease, run by Hao Liu at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

General situation of the patient (time frame: Before the operation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in